Phase IB/II Study of Lirilumab in Combination with Azacytidine (AZA) in Patients (pts) with Relapsed Acute Myeloid Leukemia (AML)
Year: 2016
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Naval Daver, Guillermo Garcia-Manero, Sreyashi Basu, Jorge E. Cortes, Farhad Ravandi, Elias J. Jabbour, Sherry Pierce, Jing Ning, Marina Konopleva, Michael Andreeff, Steven M. Kornblau, Gautam Borthakur, Naveen Pemmaraju, Carlos E Bueso-Ramos, Juliana Elisa Hidalgo Lopez, Jorge Blando, James Allison, Hagop M. Kantarjian, Padmanee Sharma
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4210465371